BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 15561981)

  • 21. IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expression.
    Tanaka F; Kawakami A; Tamai M; Nakamura H; Iwanaga N; Izumi Y; Arima K; Aratake K; Huang M; Kamachi M; Ida H; Origuchi T; Eguchi K
    Int J Mol Med; 2005 May; 15(5):833-9. PubMed ID: 15806306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells.
    Levy JB; Schindler C; Raz R; Levy DE; Baron R; Horowitz MC
    Endocrinology; 1996 Apr; 137(4):1159-65. PubMed ID: 8625884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes.
    Pan J; Fukuda K; Saito M; Matsuzaki J; Kodama H; Sano M; Takahashi T; Kato T; Ogawa S
    Circ Res; 1999 May; 84(10):1127-36. PubMed ID: 10347087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFNgamma signaling-does it mean JAK-STAT?
    Gough DJ; Levy DE; Johnstone RW; Clarke CJ
    Cytokine Growth Factor Rev; 2008; 19(5-6):383-94. PubMed ID: 18929502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
    Kunisada K; Hirota H; Fujio Y; Matsui H; Tani Y; Yamauchi-Takihara K; Kishimoto T
    Circulation; 1996 Nov; 94(10):2626-32. PubMed ID: 8921810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin signals through RUSH/SMARCA3 in the absence of a physical association with Stat5a.
    Hewetson A; Moore SL; Chilton BS
    Biol Reprod; 2004 Dec; 71(6):1907-12. PubMed ID: 15306550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK/STAT pathways are not involved in the direct activation of antigen-presenting cells by contact sensitizers.
    Valk E; Zahn S; Knop J; Becker D
    Arch Dermatol Res; 2002 Jul; 294(4):163-7. PubMed ID: 12111345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor.
    Guo D; Dunbar JD; Yang CH; Pfeffer LM; Donner DB
    J Immunol; 1998 Mar; 160(6):2742-50. PubMed ID: 9510175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissection of the cytoplasmic domains of cytokine receptors involved in STAT and Ras dependent proliferation.
    Piu F; Magnani M; Ader ME
    Oncogene; 2002 May; 21(22):3579-91. PubMed ID: 12032860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peripheral but not central axotomy induces changes in Janus kinases (JAK) and signal transducers and activators of transcription (STAT).
    Schwaiger FW; Hager G; Schmitt AB; Horvat A; Hager G; Streif R; Spitzer C; Gamal S; Breuer S; Brook GA; Nacimiento W; Kreutzberg GW
    Eur J Neurosci; 2000 Apr; 12(4):1165-76. PubMed ID: 10762348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes.
    Kunisada K; Tone E; Fujio Y; Matsui H; Yamauchi-Takihara K; Kishimoto T
    Circulation; 1998 Jul; 98(4):346-52. PubMed ID: 9711940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STAT signaling in the pathogenesis and treatment of leukemias.
    Lin TS; Mahajan S; Frank DA
    Oncogene; 2000 May; 19(21):2496-504. PubMed ID: 10851048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell density dependent increase of constitutive signal transducers and activators of transcription 3 activity in melanoma cells is mediated by Janus kinases.
    Kreis S; Munz GA; Haan S; Heinrich PC; Behrmann I
    Mol Cancer Res; 2007 Dec; 5(12):1331-41. PubMed ID: 18171991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of nocodazole on the activation of transcription factors STAT1 and STAT3 in A431 cells].
    Vasilenko KP; Burova EB; Vinogradova NA; Nikol'skiĭ NN
    Tsitologiia; 2004; 46(12):1025-9. PubMed ID: 15747831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Jak-STAT pathway.
    Imada K; Leonard WJ
    Mol Immunol; 2000; 37(1-2):1-11. PubMed ID: 10781830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Recent progresses in the JAK-STAT signaling pathways].
    Nakajima K
    Nihon Rinsho; 1998 Jul; 56(7):1763-72. PubMed ID: 9702051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of type I interferon signaling in normal and malignant cells.
    Li Y; Srivastava KK; Platanias LC
    Arch Immunol Ther Exp (Warsz); 2004; 52(3):156-63. PubMed ID: 15247882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Jak kinases and STATs in cytokine signal transduction.
    Leonard WJ
    Int J Hematol; 2001 Apr; 73(3):271-7. PubMed ID: 11345192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What are appropriate controls for cardiac interleukin-6 expression in heart failure?
    Plenz GA; Eschert H; Deng MC
    Circulation; 2003 Oct; 108(17):e129-30; author reply e129-30. PubMed ID: 14581394
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.